Organometallic ligands for the localization and quantification o

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 91, 534 10, 534 12, 534 14, 534883, 556 45, A61K 5100, A61K 4900, C07F 1300

Patent

active

060541148

ABSTRACT:
Novel organometallic compounds for binding amyloid are described. Methods using such compounds for determining by imaging the localization or quantification of amyloid fibrils in a mammal, for diagnosing the degree of progression of Alzheimer's disease in a mammal, for monitoring the response to a therapy in a mammal having Alzheimer's disease, for identifying an agent useful for treating Alzheimer's disease, for treating Alzheimer's disease, and for detecting the presence of the infectious form of the prion protein, are also described.

REFERENCES:
patent: 4933156 (1990-06-01), Quay et al.
patent: 5268164 (1993-12-01), Kozarich et al.
Saito et al., Vector-mediated delivery of .sup.125 I-labeled .beta.-amyloid peptide A.beta..sup.1-40 through blood-brain barrier and binding to Alzheimer disease amyloid of the A.beta..sup.1-40 /vector complex, PNAS USA 92: 10227-10231 (1995).
Pollack et al., Sulfonated dyes attenuate the toxic effects of .beta.-amyloid in a structure-specific fashion, Neuroscience Letters 197:211-214 (1995).
Klunk et al., Chrysamine-G binding to Alzheimer and control brain: Autopsy study of a new amyloid probe, Neurobiology of Aging 16(4):541-548 (1995).
Park, L.Y. Ph.D. Thesis, Massachusetts Institute of Technology, Cambridge, MA, pp. 94-98, 170-173, (1992).
Caughey and Raymond, Sulfated Polyanion Inhibition of Scrapie-Associated PrP Accumulation in Cultured Cells. J. of Virology, 67(2):643-650 (1993).
Lorenzo and Yankner, .beta.-amyloid neurotoxicity requires fibril formation and is inhibited by Congo red, Proc. Natl. Acad. Sci. USA 91:12243-12247 (1994).
Award and Aly, Synthesis and Antimicrobial Activity of Some New 3-Azo(p-substituted benzene-sulphonamido-)-bipyridyls and their Chelates, Synth. React. Inorg. Met.-Org. Chem. 21(3):375-383 (1991).
Calogero et al., An Approach to the Design of Non-Mutagenic Azo Dyes:2. Potential Replacements for the Benzidine Moiety of Some Mutagenic Azo Dyestuffs, Dyes Pigm. 8:431-447 (1987).
Han et al., Technetium Complexes for the Quantitation of Brain Amyloid, J. Am. Chem. Soc. 118: 4506-4507 (1996).
Madras et al., Technepine: A High-Affinity .sup.99m Technetium Probe to Label the Dopamine Transporter in Brain by SPECT Imaging, Synapse 22:239-246 (1996).
Klunk et al., Development of Small Molecule Probes for the Beta-Amyloid Protein of Alzheimer's Disease, Neurobiology of Aging 15(6):691-698 (1994).
Maggio et al., Reversible in vitro growth of Alzheimer disease .beta.-amyloid plaques by deposition of labeled amyloid peptide, Proc. Natl. Acad. Sci. USA 89:5462-5466 (1992).
Ashburn et al., Amyloid Probes Based on Congo Red Distinguish Between Fibrils Comprising Different Peptides, Chem. and Biol. 3(5):351-358 (1996).
Straub et al., Chemical Pathways of Degradation of the Bradykinin Analog, RMP-7, Pharmaceutical Research 12(2), 305-308 (1995).
Walker et al., Labeling of .beta.-Amyloid in Vivo, Abstract #98, Third International Conference on Alzheimer's Disease, pp. S23-S24 (1992).
Abrams et al., Synthesis and Characterization of Hexakis (alkyl isocyanide) and Hexakis (aryl isocyanide) Complexes of Technetium (I), Inorg. Chem. 22:2798-2800 (1983).
Juhasz and Biemann, Mass spectrometric molecular-weight determination of highly acidic compounds of biological significance via their complexes with basic polypeptides, PNAS USA 91:4333-4337 (1994).
Klunk et al., Quantitative Evaluation of Congo Red Binding to Amyloid-like Proteins with a Beta-pleated Sheet Conformation, J. Histochem. Cytochem. 37:1273-1281 (1989).
Knorpp et al., Radiosulfur (S.sup.35) Labeled Congo Red Dye, J. Nucl. Med. 1:23-20 (1960).
Neuwelt, Implications of the Blood-Brain Barrier and Its Manipulation, vol. I, Plenum Press, NY (1989), pp. 332-338 and 358-364.
Neuwelt, Implications of the Blood-Brain Barrier and Its Manipulation, vol. II, Plenum Press, NY (1989). pp. 29-33, 41-51, 207-213 and 257-258.
O'Connell et al., Technetium (I) Isocyanide Complexes with Bidentate Aromatic Amine Ligands: Structural Characterization of [Tc(CNtBu).sub.4 (bpy)]PT.sub.6, Complex with "Tc(III) Character", Inorg. Chem 29:3539-47 (1990).
Photaki et al., On Cysteine and Cystine Peptides, Part V. S-Trityl- and S-Diphenyl-methyl-cysteine and -cysteine Peptides, J. Chem. Soc. (c) 2683-2687 (1970).
Tubis et al., The Preparation and Use of Radioiodinated Congo Red in Detecting Amyloidosis, J. Am. Pharmaceutical Assn 49:422-425 (1960).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Organometallic ligands for the localization and quantification o does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Organometallic ligands for the localization and quantification o, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Organometallic ligands for the localization and quantification o will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-991153

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.